How AI might help identify adverse drug events

The development of natural language processing (NLP) capabilities is opening new avenues for pharmacovigilance and pharmacists can play a key role in the process. US...

Medication adherence through community pharmacy intervention

Community pharmacist-led interventions have been shown to improve adherence and health outcomes for patients with chronic diseases but a number of barriers remain. Researchers from...

Bringing pharmacists into the digital future

PSA has unveiled a new digital health report, Connecting the dots: Digitally empowered pharmacists, at the PSA19 conference. The report, funded by the Australian Digital...

Marea O’Donnell extended interview

As a pharmacist who cares about people, any extra involvement of having pharmacists in aged care is going to be good. It’s going to...

From the President: pharmacist prescribing

Prescribing is more than just putting pen to paper – but falls well within pharmacists’ scope of practice. Adding prescribing to the repertoire of the...

Engaging hyper-connected patients

At PSA17, I discussed how pharmacists can engage hyper-connected patients to help them avoid misinformation or misadventure. In case you missed it, here are...